2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects
Chu Hsien Lim, Brian D Kangas, Jack Bergman
July 9, 2018 DOI: 10.22186/jyi.35.2.45-49 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Population | Cancer patients |
| Intervention | Psilocybin |
| Topics | Anxiety Psilocybin |
| Keywords | Breast cancer Depression economics Intensive care medicine Hallucinogen |
| Citations | 1 |
| Key findings | Psilocybin shows potential for managing depression and anxiety in cancer patients. |
Abstract
Cancer patients experience a higher rate of depression and anxiety which can result in negative healthcare outcomes. With the limited treatment options available, there has been an interest in using psychedelics such as psilocybin to manage such complications. Recently, two studies demonstrated the